Description
Seeking adults aged 70 and older with stage IIIB-IV lung cancer for a study comparing immunotherapy and chemotherapy to immunotherapy alone.
Overview
Participants in this study will be randomly assigned to get either immunotherapy alone or their doctor's choice of chemotherapy together with immunotherapy for four 21-day cycles of treatment.
What we're hoping for
We are studying whether adding chemotherapy to the usual immunotherapy alone is better, worse, or the same for adults aged 70 and older with stage IIIB-IV lung cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT06096844